HomeXRP2 • FRA
add
Silence Therapeutics PLC - ADR
Nakaraang pagsara
€7.00
Sakop ng araw
€5.60 - €5.90
Sakop ng taon
€5.60 - €26.80
Market cap
303.06M USD
Average na Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.14M | -59.19% |
Gastos sa pagpapatakbo | 20.90M | 50.50% |
Net na kita | -27.01M | -227.42% |
Net profit margin | -2.37K | -702.21% |
Kita sa bawat share | -0.19 | 29.84% |
EBITDA | -22.42M | -78.32% |
Aktuwal na % ng binabayarang buwis | 10.43% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 128.99M | 119.33% |
Kabuuang asset | 169.38M | 72.94% |
Kabuuang sagutin | 74.87M | -3.95% |
Kabuuang equity | 94.52M | — |
Natitirang share | 47.21M | — |
Presyo para makapag-book | 3.50 | — |
Return on assets | -31.47% | — |
Return on capital | -54.35% | — |
Cash Flow
Net change in cash
| (GBP) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -27.01M | -227.42% |
Cash mula sa mga operasyon | -19.66M | -303.45% |
Cash mula sa pag-invest | -28.84M | -239.81% |
Cash mula sa financing | 5.97M | -50.40% |
Net change in cash | -47.53M | -263.37% |
Malayang cash flow | -16.74M | -175.48% |
Tungkol
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
Itinatag
1994
Website
Mga Empleyado
109
